Immix Biopharma IMMX Stock
$12.21
0.576604%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$873.49M
LOW - HIGH [24H]
$11.98
-
$12.59
VOLUME [24H]
$1.08M
P/E Ratio
0
Earnings per share
-$0.88
ISIN
US45258H1068
Immix Biopharma Price Chart
Immix Biopharma IMMX Financial and Trading Overview
| Immix Biopharma stock price | 12.21 USD |
| Previous Close | 12.14 USD |
| Open | 12.44 USD |
| Bid | 8.93 USD x 200 |
| Ask | 15.51 USD x 200 |
| Day's Range | 11.98 - 12.5 USD |
| 52 Week Range | 1.94 - 15.1 USD |
| Volume | 242.24K USD |
| Avg. Volume | 1.85M USD |
| Market Cap | 882.44M USD |
| Beta (5Y Monthly) | 0.203 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.88 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.15 USD |
IMMX Valuation Measures
| Enterprise Value | 637.38M USD |
| Trailing P/E | N/A |
| Forward P/E | -13.499316 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.8546875 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -15.364 |
Trading Information
Immix Biopharma Stock Price History
| Beta (5Y Monthly) | 0.203 |
| 52-Week Change | 480.86% |
| S&P500 52-Week Change | 15.74% |
| 52 Week High | 15.1 USD |
| 52 Week Low | 1.94 USD |
| 50-Day Moving Average | 11.22 USD |
| 200-Day Moving Average | 8.68 USD |
IMMX Share Statistics
| Avg. Volume (3 month) | 1.85M USD |
| Avg. Daily Volume (10-Days) | 1.29M USD |
| Shares Outstanding | 71.54M |
| Float | 56.17M |
| Short Ratio | 6.08 |
| % Held by Insiders | 17.13% |
| % Held by Institutions | 78.92% |
| Shares Short | 9.62M |
| Short % of Float | 16.23% |
| Short % of Shares Outstanding | 13.43% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -20.51% |
| Return on Equity (ttm) | -34.17% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -41484312 USD |
| Net Income Avi to Common (ttm) | -39917212 USD |
| Diluted EPS (ttm) | -0.88 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 232.11M USD |
| Total Cash Per Share (mrq) | 3.24 USD |
| Total Debt (mrq) | 1M USD |
| Total Debt/Equity (mrq) | 0.44 USD |
| Current Ratio (mrq) | 25.134 |
| Book Value Per Share (mrq) | 3.2 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -38498080 USD |
| Levered Free Cash Flow (ttm) | -25388076 USD |
Profile of Immix Biopharma
| Country | United States |
| State | CA |
| City | Los Angeles |
| Address | 11400 West Olympic Boulevard |
| ZIP | 90064 |
| Phone | 310 651 8041 |
| Website | https://www.immixbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 21 |
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Q&A For Immix Biopharma Stock
What is a current IMMX stock price?
Immix Biopharma IMMX stock price today per share is 12.21 USD.
How to purchase Immix Biopharma stock?
You can buy IMMX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Immix Biopharma?
The stock symbol or ticker of Immix Biopharma is IMMX.
Which industry does the Immix Biopharma company belong to?
The Immix Biopharma industry is Biotechnology.
How many shares does Immix Biopharma have in circulation?
The max supply of Immix Biopharma shares is 71.54M.
What is Immix Biopharma Price to Earnings Ratio (PE Ratio)?
Immix Biopharma PE Ratio is now.
What was Immix Biopharma earnings per share over the trailing 12 months (TTM)?
Immix Biopharma EPS is -0.88 USD over the trailing 12 months.
Which sector does the Immix Biopharma company belong to?
The Immix Biopharma sector is Healthcare.
Immix Biopharma IMMX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26186.41 USD — |
-0.56
|
6.24B USD — | 25992.55 USD — | 26329.98 USD — | — - | 6.24B USD — |
|
US Tech Health Care
IXHC
US
|
1308.52 USD — |
+1.15
|
— — | 1296.22 USD — | 1310.89 USD — | — - | — — |
- {{ link.label }} {{link}}
